Search for: "Human Genome Sciences, Inc."
Results 101 - 120
of 124
Sort by Relevance
|
Sort by Date
17 Feb 2010, 2:43 pm
This case concerns an appeal [2010] EWCA Civ. 33 from the August 2008 judgment in Eli Lilly & Co. v Human Genome Sciences Inc., [2008] EWHC 1903 (Pat), wherein Mr. [read post]
17 Feb 2010, 5:10 am
USA, Inc; Eli Lilly & Co. v. [read post]
10 Feb 2010, 4:47 pm
- UK: EWCA dismisses Human Genome Sciences appeal against decision finding invalidity; invention not ‘susceptible of industrial application’: Eli Lilly v Human Genome Sciences Inc (EPLAW) (IPKat) Nuvigil (Armodafinil) – US: Patent infringement complaints filed in Colorado and Delaware following a Paragraph IV certification as part of Sandoz's filing of an ANDA to manufacture a generic version of Cephalon's… [read post]
9 Feb 2010, 11:58 pm
In August 2008 Mr Justice Kitchin delivered a mega-judgment in Eli Lilly & Co v Human Genome Sciences Inc, [2008] EWHC 1903 (Pat) on patent validity (noted by the IPKat here). [read post]
9 Feb 2010, 3:52 am
Court of Appeal (Criminal Division) Curtis v R [2010] EWCA Crim 123 (09 February 2010) Court of Appeal (Civil Division) O’Beirne v Hudson [2010] EWCA Civ 52 (09 February 2010) Drew v Whitbread [2010] EWCA Civ 53 (09 February 2010) B, R (on the application of) v Cornwall Council & Anor [2010] EWCA Civ 55 (09 February 2010) W (Children), Re [2010] EWCA Civ 57 (09 February 2010) Eli Lilly & Co v Human Genome Sciences Inc [2010] EWCA Civ 33 (09 February… [read post]
27 Jan 2010, 3:00 am
- ‘indirect consumer tax’ to fund UN public health initiatives (Afro-IP) Canada: Submissions on Canada-EU trade deal: Canadian Generic Pharma Assoc. wants IP out (Michael Geist) Canada: Intellectual property and agriculture – CDC Triffid seed story (ipblog.ca) EU: Records of the 1st, 2nd and 3rd expert meetings on SPCs (The SPC Blog) EU: Cooperation between Board of Appeal and National Court / acceleration of appeal proceedings: Human Genome Sciences v… [read post]
22 Jul 2009, 10:21 am
Following a one year clinical trial, Human Genome Sciences Inc. has announced positive results of lupus patients using Benlysta for more effective treatment of pain, hair loss, and skin rash in lupus patients. [read post]
26 May 2009, 9:59 pm
Thomas Watkins, President and Chief Executive Officer of Human Genome Sciences, Inc. [read post]
23 Dec 2008, 7:00 pm
Several highlights: Four companies adopted the proposal seeking the repeal of the classified structure of the board of directors and calling for the annual election of all directors: Cumulus Media, Inc.; Human Genome Sciences; O'Charley's Inc.; and Stone Energy Corporation. [read post]
19 Dec 2008, 1:00 pm
(IP Kenya) UK: Damages for observing patent injunction: Les Laboratoires Servier & Anor v Apotex Inc & Ors (IP finance) US/China: ‘Eli Lilly lobbies on counterfeiting and regulatory issues involving China’ (IP Dragon) US: Federal judge dismisses patent lawsuit filed by Human Genome Sciences against Genentech over patent related to type of protein that can be used to detect tumours (Law360) US: MedImmune seeks invalidation of… [read post]
19 Dec 2008, 8:07 am
" Human Genome Sciences Inc. v. [read post]
1 Oct 2008, 12:00 pm
It has been revised to take into account, among other things, recent case law including the House of Lords judgment in Angiotech (IPKat commentary here) and the Patents Court judgments in Eli Lilly & Co. v Human Genome Sciences, Inc. [read post]
16 Aug 2008, 2:43 am
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: Belgium - eBay wins ruling against L’Oreal in dispute over liability for counterfeit goods sold in online auctions: (Managing Intellectual Property), (Counterfeit Chic), (IPKat), (Class 46), (Techdirt), (Ars Technica) US CAFC holds that copying free software without complying with license is copyright infringement: Robert Jacobsen v… [read post]
9 Aug 2008, 1:50 am
: (Seattle Trademark Lawyer) Global - Patents Global science – threat to local innovation? [read post]
4 Aug 2008, 10:57 am
Court of Appeal (Criminal Division) Laku, R v [2008] EWCA Crim 1745 (16 July 2008) Wilson, R v [2008] EWCA Crim 1754 (15 July 2008) Sivaraman, R. v [2008] EWCA Crim 1736 (24 July 2008) Islam, R v [2008] EWCA Crim 1740 (31 July 2008) Court of Appeal (Civil Division) Perry & Anor v Harris (A Minor) [2008] EWCA Civ 907 (31 July 2008) Jirehouse Capital & Anor v Beller & Anor [2008] EWCA Civ 908 (30 July 2008) Secretary of State for the Environment Food & Rural Affairs v… [read post]
2 Aug 2008, 12:54 am
: (Holman’s Biotech IP Blog), Daiichi’s open offer for 20% in Ranbaxy awaits Sebi nod: (GenericsWeb), Australia/India: Strides shows thumbs up for Indian generic industry acquiring controlling interest in Ascent: (Spicy IP), Europe: Significant date ahead for EU Paediatric Regulation: (SPC Blog), India: Grave diggers, ‘immoral’ patent and the National Biotech Regulatory Authority: (Spicy IP), UK: Monster trade mark infringement case: court reveals its thinking… [read post]
1 Aug 2008, 10:24 am
High Court (Family Division) Z County Council v TS & Ors [2008] EWHC 1773 (Fam) (25 July 2008) SW v SW & Anor [2008] EWHC 1890 (Fam) (31 July 2008) High Court (Patents Court) Re Council Regulation (EEC) No 1768/92 [2008] EWHC 1902 (Pat) (31 July 2008) Eli Lilly & Company v Human Genome Sciences Inc [2008] EWHC 1903 (Pat) (31 July 2008) Source: www.bailii.org. [read post]
1 Aug 2008, 7:24 am
Yesterday Mr Justice Kitchin delivered a mega-judgment in Eli Lilly & Co v Human Genome Sciences Inc, [2008] EWHC 1903 (Pat), yet another significant Patents Court for England and Wales decision on patent validity.In short, HGS owned a patent that disclosed the nucleotide and amino acid sequence of a novel member of the TNF ligand superfamily, the polypeptide Neutrokine-Ã [read post]
20 Jun 2008, 8:07 am
: (Spicy IP), Latin America: Merck Serono signs distribution agreement with Bristol-Myers Squibb for portfolio of established pharmaceutical brands in Latin America: (IP tango), US: Biotech industry growth to slow due to funding pressures and competition from biosimilars: (Managing Intellectual Property), US: House Commerce Committee posts responses to its questions on biogenerics; not surprisingly, the views run the gamut: (FDA Law Blog), US: Biosimilar debate heats up at BIO: (Managing… [read post]
11 Apr 2008, 9:00 am
’ – 18 – 22 June, US/Alaska: (Public Knowledge), Center for IP 8th Annual IP Symposium – 28-30 May, Maryland US: (Public Knowledge), University of Maastricht: Conference on public health, innovation and intellectual property – 15 April, Maastricht (Netherlands): (IPR-Helpdesk), NLSIU Symposium: ‘Challenges to India’s patent regime’ – 12-13 April: (Spicy IP), Anti-counterfeiting and brand… [read post]
